JP2021534144A5 - - Google Patents

Info

Publication number
JP2021534144A5
JP2021534144A5 JP2021507529A JP2021507529A JP2021534144A5 JP 2021534144 A5 JP2021534144 A5 JP 2021534144A5 JP 2021507529 A JP2021507529 A JP 2021507529A JP 2021507529 A JP2021507529 A JP 2021507529A JP 2021534144 A5 JP2021534144 A5 JP 2021534144A5
Authority
JP
Japan
Prior art keywords
cells
age
modified
antibody
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021507529A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021534144A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/047762 external-priority patent/WO2020041625A1/en
Publication of JP2021534144A publication Critical patent/JP2021534144A/ja
Publication of JP2021534144A5 publication Critical patent/JP2021534144A5/ja
Priority to JP2024098654A priority Critical patent/JP2024123124A/ja
Ceased legal-status Critical Current

Links

JP2021507529A 2018-08-23 2019-08-22 Age修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波 Ceased JP2021534144A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024098654A JP2024123124A (ja) 2018-08-23 2024-06-19 Age修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862721932P 2018-08-23 2018-08-23
US62/721,932 2018-08-23
PCT/US2019/047762 WO2020041625A1 (en) 2018-08-23 2019-08-22 Anti carboxymethyl lysine antibodies and ultrasound for removing age-modified cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024098654A Division JP2024123124A (ja) 2018-08-23 2024-06-19 Age修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波

Publications (2)

Publication Number Publication Date
JP2021534144A JP2021534144A (ja) 2021-12-09
JP2021534144A5 true JP2021534144A5 (cg-RX-API-DMAC7.html) 2023-05-26

Family

ID=68063013

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021507529A Ceased JP2021534144A (ja) 2018-08-23 2019-08-22 Age修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波
JP2024098654A Pending JP2024123124A (ja) 2018-08-23 2024-06-19 Age修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024098654A Pending JP2024123124A (ja) 2018-08-23 2024-06-19 Age修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波

Country Status (4)

Country Link
US (1) US20210253739A1 (cg-RX-API-DMAC7.html)
EP (1) EP3840840A1 (cg-RX-API-DMAC7.html)
JP (2) JP2021534144A (cg-RX-API-DMAC7.html)
WO (1) WO2020041625A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102037119B (zh) 2008-05-23 2015-06-24 Siwa有限公司 促进再生的方法、组合物及设备
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
AU2015318036B2 (en) 2014-09-19 2021-07-01 Siwa Corporation Anti-AGE antibodies for treating inflammation and auto-immune disorders
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
IL283726B2 (en) 2016-02-19 2025-05-01 Siwa Corp A preparation containing an antibody to advanced glycation end products (AGE) for use in the treatment of breast cancer
EP3443007A1 (en) 2016-04-15 2019-02-20 Siwa Corporation Anti-age antibodies for treating neurodegenerative disorders
US11213585B2 (en) 2016-06-23 2022-01-04 Siwa Corporation Vaccines for use in treating various diseases and disorders
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
BR112019021471A2 (pt) 2017-04-13 2020-05-12 Siwa Corporation Anticorpo monoclonal humanizado de produto final da glicação avançada
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications
CN115397967A (zh) 2020-04-28 2022-11-25 美国西门子医学诊断股份有限公司 声电泳裂解设备和方法
US20230181730A1 (en) * 2020-05-01 2023-06-15 Siwa Corporation Methods of treating infections
WO2021247397A2 (en) * 2020-06-04 2021-12-09 Siwa Corporation Methods and compositions for enhancing the immune system
WO2022093195A1 (en) * 2020-10-27 2022-05-05 Siwa Corporation Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens
EP4561696A4 (en) * 2022-06-30 2026-07-15 Mechanobiologics Inc REVERSAL OF CELLULAR SENENCE BY LOW-FREQUENCY ULTRASOUND TREATMENT
KR20260030241A (ko) * 2024-08-27 2026-03-06 한국과학기술원 조직 내 최종당화산물 제거 방법, 및 이를 이용한 노화 억제 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624804A (en) 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products
US6380165B1 (en) 1997-09-19 2002-04-30 The Picower Institute For Medical Research Immunological advanced glycation endproduct crosslink
US6067859A (en) 1999-03-04 2000-05-30 The Board Of Regents, The University Of Texas System Optical stretcher
US7751057B2 (en) 2008-01-18 2010-07-06 The Board Of Trustees Of The University Of Illinois Magnetomotive optical coherence tomography
CN102037119B (zh) * 2008-05-23 2015-06-24 Siwa有限公司 促进再生的方法、组合物及设备
WO2011101039A1 (en) 2010-02-22 2011-08-25 Universite Pierre Et Marie Curie (Paris 6) Apparatus for the treatment of brain affections and method implementing thereof
WO2012047629A2 (en) * 2010-09-27 2012-04-12 Siwa Corporation Selective removal of age-modified cells for treatment of ather0sclerosis
US20140257262A1 (en) 2013-03-11 2014-09-11 Alexandre Carpentier Interstitial ultrasonic disposable applicator and method for tissue thermal conformal volume ablation and monitoring the same
AU2015318036B2 (en) * 2014-09-19 2021-07-01 Siwa Corporation Anti-AGE antibodies for treating inflammation and auto-immune disorders
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
BR112018007422A2 (pt) * 2015-10-13 2018-10-30 Siwa Corp anticorpos anti-age e métodos de uso dos mesmos
WO2017080481A1 (en) * 2015-11-11 2017-05-18 Navifus Co., Ltd. Method and kit for treating brain tumor by using ultrasound system
IL283726B2 (en) 2016-02-19 2025-05-01 Siwa Corp A preparation containing an antibody to advanced glycation end products (AGE) for use in the treatment of breast cancer
US10981021B2 (en) 2016-03-11 2021-04-20 Carthera Method for transiently disrupting a region of the blood-brain barrier of a human
EP3443007A1 (en) 2016-04-15 2019-02-20 Siwa Corporation Anti-age antibodies for treating neurodegenerative disorders

Similar Documents

Publication Publication Date Title
JP2021532114A5 (cg-RX-API-DMAC7.html)
JP2016519932A5 (cg-RX-API-DMAC7.html)
Brand et al. Secretory carrier membrane proteins 31-35 define a common protein composition among secretory carrier membranes.
Deshpande Enzyme immunoassays: from concept to product development
BRPI0507433B8 (pt) anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit
WO2018057735A8 (en) Antibodies for siglec-15 and methods of use thereof
NZ701444A (en) Antibodies to matrix metalloproteinase 9
NZ623541A (en) Human cgrp receptor binding proteins
JP2019522490A5 (cg-RX-API-DMAC7.html)
EA201100527A1 (ru) Биологические продукты
JP2014502253A5 (cg-RX-API-DMAC7.html)
Tillib et al. Single-domain antibody-based ligands for immunoaffinity separation of recombinant human lactoferrin from the goat lactoferrin of transgenic goat milk
JPS62162963A (ja) 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
Jones et al. Isolation of immune complexes and characterisation of their constituent antigens and antibodies in some human diseases: a review
Reese et al. Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands
US11169147B2 (en) Method for immobilizing protein on particle
MX2024002150A (es) Anticuerpos y proteinas de fusion de igg con una semivida prolongada.
EA201100741A1 (ru) Антитела к модифицированным пептидам ифр-1/е человека
Abdel-Rahman et al. Preparation of goat and rabbit anti-camel immunoglobulin G whole molecule labeled with horseradish peroxidase
WO2023196658A3 (en) Antibody compositions and optimization methods
Ma et al. The purification of natural and recombinant peptide antibodies by affinity chromatographic strategies
IL148598A (en) Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it
Nakazawa et al. Production and purification of polyclonal antibodies
CN115362171A (zh) 用于治疗冠状病毒的抗体、融合蛋白及其应用
Yu et al. Method for studying immunoglobulin G binding on hydrophobic surfaces